Who invested in Akarna Therapeutics?
2 investors are on record as having backed Akarna Therapeutics — Small molecule therapy for NASH, in Biotech. Each row below says whether the round came from the investor's own portfolio page or from the press.
akarna.comAkarna Therapeutics investors
Nsv Management LLCInvests in early and late stage life sciences and IT companies using novel scientific…their site
Third Point LLCBacks trailblazing founders with deep technical expertise, go-to-market experience, and…their site
No round dates are on record for Akarna Therapeutics. A portfolio page names its companies far more often than it dates the cheque, and we would rather leave the field empty than guess it.
The funds that backed Akarna Therapeutics are in the directory.
If they wrote this cheque, they may write yours. Pitch2Fund scores your startup against every one of them, gives you the partner to write to, and drafts the email. Free.